The increased levels of ACE2 mRNA in blood samples from COVID-19 patients were similar to those observed in A549 lung carcinoma epithelial cells following ACE2 transfection and/or SARS-CoV-2 infection (Fig. 1c; GEO: GSE147507). This evidence concerns the gene ACE2 and COVID-19.